A Phase I study of an intravesically administered immunotoxin targeting EpCAM for the treatment of nonmuscle-invasive bladder cancer in BCGrefractory and BCG-intolerant patients (Q34389519)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Phase I study of an intravesically administered immunotoxin targeting EpCAM for the treatment of nonmuscle-invasive bladder cancer in BCGrefractory and BCG-intolerant patients |
scientific article |
Statements
1 reference
A Phase I study of an intravesically administered immunotoxin targeting EpCAM for the treatment of nonmuscle-invasive bladder cancer in BCGrefractory and BCG-intolerant patients (English)
1 reference
Mark Kowalski
1 reference
Joycelyn Entwistle
1 reference
Jeannick Cizeau
1 reference
Demi Niforos
1 reference
Shauna Loewen
1 reference
Wendy Chapman
1 reference
Glen C MacDonald
1 reference
15 November 2010
1 reference
1 reference
4
1 reference
313-320
1 reference
1 November 2010
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference